Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4120704 | 0.86 | DPP4 (0.43) | DPP4 | |
| SCHEMBL4120727 | 0.85 | DPP4 (0.38) | DPP4 | |
| SCHEMBL4121228 | 0.78 | DPP4 (0.62) | DPP4OPRD1 | |
| SCHEMBL13039193 | 0.74 | MLYCD (0.37) | DPP4OPRD1 | |
| SCHEMBL15995187 | 0.71 | DPP4 (0.37) | DPP4OPRD1 | |
| SCHEMBL7608080 | 0.71 | TSHR (0.33) | DPP4 | |
| SCHEMBL13895343 | 0.70 | MMP1 (0.38) | DPP4OPRD1 | |
| SCHEMBL13185662 | 0.67 | LMNA (0.37) | DPP4 | |
| SCHEMBL4128353 | 0.67 | DNM1 (0.39) | — | |
| SCHEMBL2755868 | 0.66 | LMNA (0.39) | OPRD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8431565-B2 | Substituted imidazoheterocycles | CARA THERAPEUTICS, INC. (US) | 2013-04-30 | — | — | US | claimed |
| US-20090149450-A1 | SUBSTITUTED IMIDAZOHETEROCYCLES | CARA THERAPEUTICS, INC. (US) | 2009-06-11 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090149450-A1 | SUBSTITUTED IMIDAZOHETEROCYCLES | CNR1, CNR2, TRPV1 | DPP4 4359/4885OPRD1 20/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.